M&A Deal Summary |
|
|---|---|
| Date | 2017-01-10 |
| Target | Derma Sciences |
| Sector | Medical Products |
| Buyer(s) | Integra LifeSciences |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1989 |
| Sector | Medical Products |
| Employees | 4,396 |
| Revenue | 1.6B USD (2024) |
Integra LifeSciences is a major medical technology dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra LifeSciences was founded in 1989 and is based in Princeton, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 41 of 45 |
| Sector: Medical Products M&A | 34 of 38 |
| Type: Add-on Acquisition M&A Deals | 31 of 33 |
| State: New Jersey M&A | 2 of 2 |
| Country: United States M&A | 34 of 38 |
| Year: 2017 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-07-20 |
TEI Biosciences
Waltham, Massachusetts, United States TEI Biosciences, Inc. is a biomedical company that applies its expertise in regenerative medicine to develop and commercialize novel biologic devices, including SurgiMend®, for a broad spectrum of soft tissue repair and regeneration applications – from dura and hernia repair to plastic and reconstructive surgery. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-02-15 |
Johnson & Johnson - Codman Neurosurgery Business
Raynham, Massachusetts, United States Johnson & Johnson - Codman Neurosurgery Business is a global neurosurgery and neurovascular company that offers a broad portfolio of devices for hydrocephalus management, neuro intensive care and cranial surgery, as well as aneurysm coils, vascular reconstruction devices and other technologies used in the endovascular treatment of cerebral aneurysms and stroke. |
Buy | $1.0B |
